Understanding CKD Staging for Pakistani Clinicians

Introduction

Chronic Kidney Disease (CKD) is a growing health concern in Pakistan, with an estimated prevalence of 12-15% in the adult population. Early detection and appropriate staging are crucial for preventing progression to end-stage renal disease (ESRD).

CKD Classification

CKD is classified based on:

1. Cause (diabetes, hypertension, glomerulonephritis, etc.)
2. eGFR category (G1-G5)
3. Albuminuria category (A1-A3)

eGFR Categories

Albuminuria Categories

Screening Recommendations

Who should be screened for CKD in Pakistan?

• Patients with diabetes mellitus (type 1 and type 2)
• Hypertensive patients
• Cardiovascular disease patients
• Family history of kidney disease
• Age >60 years
• Patients with recurrent UTIs, nephrolithiasis
• Patients taking nephrotoxic medications (NSAIDs, some antibiotics)

Screening tests:

• Serum creatinine (with eGFR calculation)
• Urine albumin-to-creatinine ratio (ACR)
• Urinalysis

Management by Stage

Stage G1-G2 (Early CKD)

• Identify and treat cause
• BP target: <130/80 mmHg (ACE inhibitors or ARBs as first-line)
• Glycemic control: HbA1c <7% (or <7.5% in elderly)
• Lifestyle modifications: low-salt diet, exercise, smoking cessation
• Avoid nephrotoxic medications
• Annual monitoring

Stage G3a-G3b (Moderate CKD)

• All G1-G2 measures plus:
• Monitor for complications: anaemia, metabolic acidosis, mineral bone disease
• Hb target: 10-11.5 g/dL; consider iron supplementation and ESA if needed
• Vitamin D: monitor 25-OH vitamin D and supplement if deficient
• Phosphate binders: start if phosphate levels elevated
• Referral to nephrologist if eGFR <30 or rapidly declining
• 6-monthly monitoring

Stage G4 (Severe CKD)

• All above measures plus:
• Prepare for renal replacement therapy (RRT)
• Dietary counselling (protein restriction: 0.6-0.8 g/kg/day)
• Manage uraemic symptoms
• Vaccinations: Hepatitis B, influenza, pneumococcal
• 3-monthly monitoring

Stage G5 (Kidney Failure)

• RRT options: haemodialysis, peritoneal dialysis, renal transplantation
• Conservative care if appropriate
• Multidisciplinary team involvement

Common CKD Complications

1. Anaemia: start ESA when Hb <10 g/dL (target 10-11.5 g/dL)
2. Metabolic acidosis: serum bicarbonate target >22 mEq/L; consider oral bicarbonate
3. Mineral bone disease: monitor Ca, PO4, PTH; use vitamin D analogues and phosphate binders
4. Hyperkalemia: dietary restriction, avoid K-sparing diuretics, consider potassium binders
5. Fluid overload: restrict sodium (2-3 g/day), loop diuretics

Medications to Avoid or Adjust in CKD

When to Refer to a Nephrologist

• eGFR <30 mL/min/1.73m²
• Rapid decline in eGFR (>5 mL/min/year)
• Significant albuminuria (ACR >30 mg/mmol)
• Uncontrolled hypertension despite 3+ agents
• Suspected glomerulonephritis (haematuria, active urine sediment)
• Complications of CKD (anaemia, metabolic acidosis, hyperkalemia)
• Family history of hereditary kidney disease

Disclaimer: This article is for educational purposes only. Clinical decisions should be made based on individual patient circumstances and specialist consultation.